NO20012825L - Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering - Google Patents
Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhaleringInfo
- Publication number
- NO20012825L NO20012825L NO20012825A NO20012825A NO20012825L NO 20012825 L NO20012825 L NO 20012825L NO 20012825 A NO20012825 A NO 20012825A NO 20012825 A NO20012825 A NO 20012825A NO 20012825 L NO20012825 L NO 20012825L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- particles
- inhalation
- powders
- preparation
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 4
- 239000000843 powder Substances 0.000 title abstract 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glanulating (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Carbon And Carbon Compounds (AREA)
- Glass Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827145.5A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012825L true NO20012825L (no) | 2001-06-08 |
| NO20012825D0 NO20012825D0 (no) | 2001-06-08 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012825A NO20012825D0 (no) | 1998-12-09 | 2001-06-08 | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (no) |
| EP (1) | EP1137399B1 (no) |
| JP (1) | JP4410942B2 (no) |
| KR (1) | KR20010101138A (no) |
| CN (1) | CN1334723A (no) |
| AT (1) | ATE240093T1 (no) |
| AU (1) | AU770461B2 (no) |
| BR (1) | BR9916102A (no) |
| CA (1) | CA2353448C (no) |
| CZ (1) | CZ20012043A3 (no) |
| DE (1) | DE69907951T2 (no) |
| DK (1) | DK1137399T3 (no) |
| EA (1) | EA004045B1 (no) |
| ES (1) | ES2198973T3 (no) |
| GB (1) | GB9827145D0 (no) |
| HU (1) | HUP0104513A3 (no) |
| MX (1) | MXPA01005584A (no) |
| NO (1) | NO20012825D0 (no) |
| NZ (1) | NZ511965A (no) |
| PL (1) | PL348831A1 (no) |
| PT (1) | PT1137399E (no) |
| SK (1) | SK284775B6 (no) |
| TR (1) | TR200101591T2 (no) |
| WO (1) | WO2000033811A2 (no) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| ES2395096T3 (es) | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| CA2413692C (en) * | 2000-06-27 | 2011-10-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| EP2266549B1 (en) * | 2000-06-27 | 2019-08-07 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| DK1920763T3 (da) | 2000-11-30 | 2014-07-07 | Vectura Ltd | Farrmaceutiske præparater til inhalation |
| DK2283818T3 (en) † | 2000-11-30 | 2017-10-16 | Vectura Ltd | Process for preparing particles for use in a pharmaceutical composition |
| US8580306B2 (en) * | 2000-11-30 | 2013-11-12 | Vectura Limited | Particles for use in a pharmaceutical composition |
| JP4368198B2 (ja) | 2001-11-20 | 2009-11-18 | アルカーメス，インコーポレイテッド | 肺送達用の改良された粒状組成物 |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| AU2003230689B2 (en) * | 2002-03-20 | 2006-06-29 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| SI1494732T1 (sl) | 2002-03-20 | 2008-08-31 | Mannking Corp | Inhalacijski aparat |
| AU2003218308B2 (en) * | 2002-03-20 | 2006-07-20 | Advanced Inhalation Research, Inc. | hGH (human growth hormone) formulations for pulmonary administration |
| WO2004089374A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
| BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| CN101243130B (zh) * | 2005-08-05 | 2011-12-07 | 3M创新有限公司 | 显示具有改善的流动性的组合物 |
| KR101486829B1 (ko) | 2005-09-14 | 2015-01-29 | 맨카인드 코포레이션 | 결정질 미립자 표면에 대한 활성제의 친화력의 증가를 기반으로 하는 약물 제제의 방법 |
| GB0525254D0 (en) | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
| DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| US8785396B2 (en) * | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| EP2222676A4 (en) | 2007-12-21 | 2011-10-26 | Endacea Inc | A1-adenosine receptor antagonistic |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| TWI677355B (zh) | 2008-06-13 | 2019-11-21 | 美商曼凱公司 | 用於藥物傳輸之乾粉吸入器及系統 |
| ES2421385T3 (es) | 2008-06-20 | 2013-09-02 | Mannkind Corp | Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| EP3578169B1 (en) | 2009-02-26 | 2024-06-26 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| EP2676695A3 (en) | 2009-03-11 | 2017-03-01 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| MY186975A (en) | 2009-06-12 | 2021-08-26 | Mannkind Corp | Diketopiperazine microparticles with defined specific surface areas |
| US9016147B2 (en) | 2009-11-03 | 2015-04-28 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| WO2011094208A2 (en) | 2010-01-26 | 2011-08-04 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
| MX359281B (es) | 2010-06-21 | 2018-09-21 | Mannkind Corp | Sistema y metodos para suministrar un farmaco en polvo seco. |
| US20130164338A1 (en) * | 2010-08-30 | 2013-06-27 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| RU2640921C2 (ru) | 2010-09-29 | 2018-01-12 | Пулмэтрикс, Инк. | Катионы одновалентных металлов сухих порошков для ингаляций |
| JP6092113B2 (ja) * | 2010-11-09 | 2017-03-08 | マンカインド コーポレイション | セロトニン受容体アゴニストおよびジケトピペラジンを含む偏頭痛治療のための組成物 |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| US8925726B2 (en) | 2011-04-01 | 2015-01-06 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
| RU2448717C1 (ru) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения антикоагулянтно-фибринолитического средства на основе гепарина |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| CA2879317C (en) | 2011-08-01 | 2019-01-15 | Monash University | Method and formulation for inhalation |
| CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
| CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
| EP2970149B1 (en) | 2013-03-15 | 2019-08-21 | MannKind Corporation | Microcrystalline diketopiperazine compositions and methods |
| MX2015013845A (es) | 2013-04-01 | 2016-05-09 | Pulmatrix Inc | Polvos secos de tiotropio. |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| CN105517607A (zh) | 2013-08-05 | 2016-04-20 | 曼金德公司 | 吹入设备和方法 |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CA2965759C (en) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials |
| ES2908479T3 (es) | 2015-08-26 | 2022-04-29 | Achillion Pharmaceuticals Inc | Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| CN109790143A (zh) | 2016-05-10 | 2019-05-21 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| SG11201811491YA (en) | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| KR102632860B1 (ko) | 2017-03-01 | 2024-02-02 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물 |
| RU2770039C2 (ru) * | 2017-03-07 | 2022-04-14 | Филип Моррис Продактс С.А. | Вдыхаемые составы на основе никотина и способы их получения и применения |
| CN110769822A (zh) | 2017-06-20 | 2020-02-07 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| US20190177588A1 (en) * | 2017-12-12 | 2019-06-13 | Xotramorphic LLC | Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects |
| JP2021519337A (ja) | 2018-03-26 | 2021-08-10 | シー４ セラピューティクス， インコーポレイテッド | Ｉｋａｒｏｓの分解のためのセレブロン結合剤 |
| CN110441198A (zh) * | 2018-05-03 | 2019-11-12 | 人福普克药业（武汉）有限公司 | 一种检测尼达尼布软胶囊中尼达尼布粒径的方法 |
| WO2020041301A1 (en) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| BR112021019669A2 (pt) | 2019-04-12 | 2021-12-07 | C4 Therapeutics Inc | Composto, composição farmacêutica, método para tratar um transtorno, composto para uso na produção de um medicamento, e, uso de um composto no tratamento de um transtorno |
| WO2021127452A1 (en) | 2019-12-19 | 2021-06-24 | Georgia State University Research Foundation, Inc. | Compounds for the treatment of bacterial infections and potentiation of antibiotics |
| EP4107166A4 (en) | 2020-02-20 | 2024-06-26 | Achillion Pharmaceuticals, Inc. | HETEROARYL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D-MEDIATED DISORDERS |
| WO2021178920A1 (en) | 2020-03-05 | 2021-09-10 | C4 Therapeutics, Inc. | Compounds for targeted degradation of brd9 |
| JP7787164B2 (ja) | 2020-09-23 | 2025-12-16 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体媒介性障害の治療のための医薬化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| ATE287703T1 (de) | 1995-04-14 | 2005-02-15 | Nektar Therapeutics | Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| ES2343124T3 (es) * | 1999-10-29 | 2010-07-23 | Novartis Ag | Composiciones de polvo seco con dispersabilidad mejorada. |
-
1998
- 1998-12-09 GB GBGB9827145.5A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
- 1999-12-09 AT AT99958404T patent/ATE240093T1/de not_active IP Right Cessation
- 1999-12-09 PT PT99958404T patent/PT1137399E/pt unknown
- 1999-12-09 EP EP99958404A patent/EP1137399B1/en not_active Expired - Lifetime
- 1999-12-09 BR BR9916102-8A patent/BR9916102A/pt not_active Application Discontinuation
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/cs unknown
- 1999-12-09 PL PL99348831A patent/PL348831A1/xx not_active IP Right Cessation
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/en not_active Ceased
- 1999-12-09 SK SK777-2001A patent/SK284775B6/sk unknown
- 1999-12-09 CN CN99816052A patent/CN1334723A/zh active Pending
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/es unknown
- 1999-12-09 CA CA2353448A patent/CA2353448C/en not_active Expired - Fee Related
- 1999-12-09 KR KR1020017007067A patent/KR20010101138A/ko not_active Ceased
- 1999-12-09 NZ NZ511965A patent/NZ511965A/en not_active IP Right Cessation
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/ja not_active Expired - Fee Related
- 1999-12-09 DK DK99958404T patent/DK1137399T3/da active
- 1999-12-09 EA EA200100636A patent/EA004045B1/ru not_active IP Right Cessation
- 1999-12-09 ES ES99958404T patent/ES2198973T3/es not_active Expired - Lifetime
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/xx unknown
- 1999-12-09 HU HU0104513A patent/HUP0104513A3/hu unknown
- 1999-12-09 DE DE69907951T patent/DE69907951T2/de not_active Expired - Lifetime
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE240093T1 (de) | 2003-05-15 |
| US6989155B1 (en) | 2006-01-24 |
| JP2002531487A (ja) | 2002-09-24 |
| EA200100636A1 (ru) | 2001-12-24 |
| MXPA01005584A (es) | 2003-07-14 |
| GB9827145D0 (en) | 1999-02-03 |
| SK7772001A3 (en) | 2001-12-03 |
| HUP0104513A2 (hu) | 2002-03-28 |
| SK284775B6 (sk) | 2005-11-03 |
| NZ511965A (en) | 2003-09-26 |
| AU770461B2 (en) | 2004-02-19 |
| HUP0104513A3 (en) | 2003-12-29 |
| AU1577700A (en) | 2000-06-26 |
| DE69907951T2 (de) | 2004-03-11 |
| EP1137399B1 (en) | 2003-05-14 |
| PT1137399E (pt) | 2003-09-30 |
| ES2198973T3 (es) | 2004-02-01 |
| BR9916102A (pt) | 2001-09-04 |
| EP1137399A2 (en) | 2001-10-04 |
| DE69907951D1 (de) | 2003-06-18 |
| WO2000033811A3 (en) | 2000-10-12 |
| DK1137399T3 (da) | 2003-08-18 |
| CZ20012043A3 (cs) | 2001-12-12 |
| WO2000033811A2 (en) | 2000-06-15 |
| JP4410942B2 (ja) | 2010-02-10 |
| CA2353448C (en) | 2010-02-23 |
| EA004045B1 (ru) | 2003-12-25 |
| CN1334723A (zh) | 2002-02-06 |
| NO20012825D0 (no) | 2001-06-08 |
| TR200101591T2 (tr) | 2001-11-21 |
| CA2353448A1 (en) | 2000-06-15 |
| PL348831A1 (en) | 2002-06-17 |
| KR20010101138A (ko) | 2001-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012825L (no) | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering | |
| GB9807232D0 (en) | Aerosol composition | |
| AP1861A (en) | Dry powder inhalation system for transpulmonary administration | |
| CA2277913A1 (en) | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof | |
| AU2003258706A1 (en) | Powder inhaler | |
| DK1131059T3 (da) | Tørpulver til inhalation | |
| CA2183577A1 (en) | Methods and compositions for pulmonary delivery of insulin | |
| CA2211874A1 (en) | Carrier particles for use in dry powder inhalers | |
| WO2005025535A8 (en) | Methods for preparing pharmaceutical compositions | |
| TR200101442T2 (tr) | HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi | |
| WO2003087335A3 (en) | Preservation of bioactive materials by spray drying | |
| PL343342A1 (en) | Particulate active agent support for pulmonary application | |
| CA2226657A1 (en) | Improvements in and relating to powders for use in dry powder inhalers | |
| CA2277914A1 (en) | New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide | |
| IS5109A (is) | Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur formóteról | |
| MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
| MXPA03003785A (es) | Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos. | |
| CA2413692A1 (en) | Method of making particles for use in a pharmaceutical composition | |
| MX2022015578A (es) | Composiciones en polvo de anatabina. | |
| GB2528945A (en) | Adsorbent particle process management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |